LCZ696, the First-in-Class Angiotensin Receptor Neprilysin Inhibitor, Improves Vascular Reactivity in the Setting of Heart Failure. (November 2017)

Record Type:: Journal Article
Title:: LCZ696, the First-in-Class Angiotensin Receptor Neprilysin Inhibitor, Improves Vascular Reactivity in the Setting of Heart Failure. (November 2017)
Main Title:: LCZ696, the First-in-Class Angiotensin Receptor Neprilysin Inhibitor, Improves Vascular Reactivity in the Setting of Heart Failure
Authors:: Trivedi, Rishi K.
Li, Zhen
Polhemus, David J.
Yoo, Daniel
Koiwaya, Hiroshi
Goodchild, Traci T.
Lefer, David J.
Abstract:
Is Part Of:: Journal of molecular and cellular cardiology. Volume 112(2017)
Journal:: Journal of molecular and cellular cardiology
Issue:: Volume 112(2017)
Issue Display:: Volume 112, Issue 2017 (2017)
Year:: 2017
Volume:: 112
Issue:: 2017
Issue Sort Value:: 2017-0112-2017-0000
Page Start:: 162
Page End:
Publication Date:: 2017-11
Subjects:: Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12
Journal URLs:: http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.yjmcc.2017.07.093 ↗
Languages:: English
ISSNs:: 0022-2828
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4799.xml